FDA approves basal cell carcinoma treatment
The FDA has approved vismodegib as the first treatment for basal cell carcinoma, the most common form of skin cancer.
Skin Cancer
Cutaneous melanoma risk elevated in cancer survivors
Highest risk seen for patients with previous diagnosis of cutaneous melanoma
FDA approves melanoma diagnostic device
MelaFind, a computer-assisted melanoma-detecting device developed by MELA Sciences, has received FDA pre-market approval (PMA) for use on atypical cutaneous pigmented lesions.
Newly developed brown papules
Two patients present with newly developed brown papules. The first patient, a 45-year-old man, presented with a new mole that continues to grow and is associated with occasional pruritus and bleeding. The second patient, a 47-year-old man, presented with a 6-month history of a brown, growing “mole.” Can you differentiate between the two?
Teens and indoor tanning: communicating health risks
When discussing indoor tanning with adolescent patients, appealing to their sense of vanity can go a long way toward dissuading them from engaging in risky behaviors.
-
Loading...
-
Loading...
